Danaher (DHR) Net Cash Flow Growth (3y) (2012 - 2026)
Danaher (DHR) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -10.07% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -6.97% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 144.76% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 41.14% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 29.81% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -26.81% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 14.18% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 4.49% |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | 42.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 27, 2026 | -6.97% |
| Dec 31, 2025 | 49.84% |
| Sep 26, 2025 | -46.30% |
| Jun 27, 2025 | 23.71% |
| Mar 28, 2025 | -29.39% |
| Dec 31, 2024 | 23.07% |
| Sep 27, 2024 | 26.27% |
| Jun 28, 2024 | -92.17% |
| Mar 29, 2024 | 44.15% |
| Dec 31, 2023 | -212.13% |
| Sep 29, 2023 | 270.03% |
| Jun 30, 2023 | 5.81% |
| Mar 31, 2023 | 27.86% |
| Dec 31, 2022 | -45.27% |
| Sep 30, 2022 | -47.75% |
| Jul 1, 2022 | -34.70% |
| Apr 1, 2022 | -27.24% |
| Dec 31, 2021 | -42.75% |
| Oct 1, 2021 | -261.23% |
| Jul 2, 2021 | 205.43% |